Cost-effectiveness of community-based household tuberculosis contact management for children in Cameroon and Uganda: a modelling analysis of a cluster-randomised trial

被引:4
|
作者
Mafirakureva, Nyashadzaishe [1 ,13 ]
Tchounga, Boris K. [2 ]
Mukherjee, Sushant [3 ]
Youngui, Boris Tchakounte [2 ]
Ssekyanzi, Bob [4 ]
Simo, Leonie [2 ]
Okello, Richard F. [5 ]
Turyahabwe, Stavia [6 ]
Kuate, Albert Kuate [7 ]
Cohn, Jennifer [8 ]
Vasiliu, Anca [9 ,10 ]
Casenghi, Martina [11 ]
Atwine, Daniel [4 ,12 ]
Bonnet, Maryline [10 ]
Dodd, Peter J. [1 ]
机构
[1] Univ Sheffield, Hlth Econ & Decis Sci, Sheffield, England
[2] Elizabeth Glaser Pediat AIDS Fdn, Yaounde, Cameroon
[3] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA
[4] Epicentre, Mbarara, Uganda
[5] Elizabeth Glaser Pediat AIDS Fdn, Mbarara, Uganda
[6] Minist Hlth, Natl TB & Leprosy Program, Kampala, Uganda
[7] Minist Hlth, Natl TB Control Program, Yaounde, Cameroon
[8] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[9] Baylor Coll Med, Dept Pediat, Global TB Program, Houston, TX USA
[10] Univ Montpellier, TransVIHMI, INSERM, IRD, Montpellier, France
[11] Elizabeth Glaser Pediat AIDS Fdn, Geneva, Switzerland
[12] Mbarara Univ Sci & Technol, Mbarara, Uganda
[13] Univ Sheffield, Hlth Econ & Decis Sci, Sheffield S1 4DA, England
来源
LANCET GLOBAL HEALTH | 2023年 / 11卷 / 12期
基金
英国医学研究理事会;
关键词
ECONOMIC-EVALUATION; MORTALITY; BURDEN;
D O I
10.1016/S2214-109X(23)00451-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundWHO recommends household contact management (HCM) including contact screening and tuberculosis-preventive treatment (TPT) for eligible children. The CONTACT trial found increased TPT initiation and completion rates when community health workers were used for HCM in Cameroon and Uganda. Methods We did a cost-utility analysis of the CONTACT trial using a health-system perspective to estimate the health impact, health-system costs, and cost-effectiveness of community-based versus facility-based HCM models of care. A decision-analytical modelling approach was used to evaluate the cost-effectiveness of the intervention compared with the standard of care using trial data on cascade of care, intervention effects, and resource use. Health outcomes were based on modelled progression to tuberculosis, mortality, and discounted disability-adjusted life-years (DALYs) averted. Health-care resource use, outcomes, costs (2021 US$), and cost-effectiveness are presented.Findings For every 1000 index patients diagnosed with tuberculosis, the intervention increased the number of TPT courses by 1110 (95% uncertainty interval 894 to 1227) in Cameroon and by 1078 (796 to 1220) in Uganda compared with the control model. The intervention prevented 15 (-3 to 49) tuberculosis deaths in Cameroon and 10 (-20 to 33) in Uganda. The incremental cost-effectiveness ratio was $620 per DALY averted in Cameroon and $970 per DALY averted in Uganda. Interpretation Community-based HCM approaches can substantially reduce child tuberculosis deaths and in our case would be considered cost-effective at willingness-to-pay thresholds of $1000 per DALY averted. Their impact and cost-effectiveness are likely to be greatest where baseline HCM coverage is lowest.Funding Unitaid and UK Medical Research Council.Copyright (c) 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
引用
收藏
页码:E1922 / E1930
页数:9
相关论文
共 48 条
  • [31] Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial
    Byford, Sarah
    Cary, Maria
    Barrett, Barbara
    Aldred, Catherine R.
    Charman, Tony
    Howlin, Patricia
    Hudry, Kristelle
    Leadbitter, Kathy
    Le Couteur, Ann
    McConachie, Helen
    Pickles, Andrew
    Slonims, Vicky
    Temple, Kathryn J.
    Green, Jonathan
    BMC PSYCHIATRY, 2015, 15
  • [32] Effect of provision of home-based curative health services by public sector health-care providers on neonatal survival: a community-based cluster-randomised trial in rural Pakistan
    Soofi, Sajid
    Cousens, Simon
    Turab, Ali
    Wasan, Yaqub
    Mohammed, Shah
    Ariff, Shabina
    Bhatti, Zaid
    Ahmed, Imran
    Wall, Steve
    Bhutta, Zulfiqar A.
    LANCET GLOBAL HEALTH, 2017, 5 (08): : E796 - E806
  • [33] Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data
    Booth, Neill
    Rissanen, Pekka
    Tammela, Teuvo L. J.
    Kujala, Paula
    Stenman, Ulf-Hakan
    Taari, Kimmo
    Talala, Kirsi
    Auvinen, Anssi
    PLOS ONE, 2019, 14 (11):
  • [34] Evaluating the effectiveness and cost-effectiveness of a digital, app-based intervention for depression (VMood) in community-based settings in Vietnam: Protocol for a stepped-wedge randomized controlled trial
    Chau, Leena W.
    Murphy, Jill K.
    Nguyen, Vu Cong
    Xie, Hui
    Lam, Raymond W.
    Minas, Harry
    Zheng, Yufei
    Krebs, Emanuel
    Hayashi, Kanna
    Dao, Son
    Nguyen, Xuan
    Duong, Viet Anh
    Fiume, Eugene
    O'Neil, John
    PLOS ONE, 2023, 18 (09):
  • [35] The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial
    Hirsch-Moverman, Yael
    Howard, Andrea A.
    Frederix, Koen
    Lebelo, Limakatso
    Hesseling, Anneke
    Nachman, Sharon
    Mantell, Joanne E.
    Lekhela, Tsepang
    Maama, Llang Bridget
    El-Sadr, Wafaa M.
    TRIALS, 2017, 18
  • [36] The Cost-Effectiveness of Community-Based Screening for Oral Cancer in High-Risk Males in the United States: A Markov Decision Analysis Approach
    Dedhia, Raj C.
    Smith, Kenneth J.
    Johnson, Jonas T.
    Roberts, Mark
    LARYNGOSCOPE, 2011, 121 (05) : 952 - 960
  • [37] Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial
    van Puffelen, Esther
    Polinder, Suzanne
    Vanhorebeek, Ilse
    Wouters, Pieter Jozef
    Bossche, Niek
    Peers, Guido
    Verstraete, Soren
    Joosten, Koen Felix Maria
    Van den Berghe, Greet
    Verbruggen, Sascha Cornelis Antonius Theodorus
    Mesotten, Dieter
    CRITICAL CARE, 2018, 22
  • [38] Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township
    Tomlinson, Mark
    Doherty, Tanya
    Ijumba, Petrida
    Jackson, Debra
    Lawn, Joy
    Persson, Lars Ake
    Lombard, Carl
    Sanders, David
    Daviaud, Emmanuelle
    Nkonki, Lungiswa
    Goga, Ameena
    Rohde, Sarah
    Sitrin, Deborah
    Colvin, Mark
    Chopra, Mickey
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2014, 19 (03) : 256 - 266
  • [39] Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial
    Hagen, Suzanne
    Kearney, Rohna
    Goodman, Kirsteen
    Melone, Lynn
    Elders, Andrew
    Manoukian, Sarkis
    Agur, Wael
    Best, Catherine
    Breeman, Suzanne
    Dembinsky, Melanie
    Dwyer, Lucy
    Forrest, Mark
    Graham, Margaret
    Guerrero, Karen
    Hemming, Christine
    Khunda, Aethele
    Mason, Helen
    McClurg, Doreen
    Norrie, John
    Karachalia-Sandri, Anastasia
    Thakar, Ranee
    Bugge, Carol
    TRIALS, 2020, 21 (01)
  • [40] Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial
    Suzanne Hagen
    Rohna Kearney
    Kirsteen Goodman
    Lynn Melone
    Andrew Elders
    Sarkis Manoukian
    Wael Agur
    Catherine Best
    Suzanne Breeman
    Melanie Dembinsky
    Lucy Dwyer
    Mark Forrest
    Margaret Graham
    Karen Guerrero
    Christine Hemming
    Aethele Khunda
    Helen Mason
    Doreen McClurg
    John Norrie
    Anastasia Karachalia-Sandri
    Ranee Thakar
    Carol Bugge
    Trials, 21